Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -3.01% | 72.51 | 1.0% | $1825.82m | |
| AMGN | Amgen, Inc. | -2.43% | 197.81 | 1.3% | $868.05m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.71% | 496.65 | 2.6% | $847.12m | |
| BIIB | Biogen, Inc. | -7.31% | 293.27 | 1.5% | $701.26m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -5.24% | 225.48 | 1.9% | $548.05m | |
| MRNA | Moderna, Inc. | -0.94% | 29.67 | 0.0% | $496.02m | |
| ILMN | Illumina, Inc. | -6.10% | 256.46 | 3.5% | $445.50m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.16% | 89.93 | 2.0% | $283.26m | |
| A | Agilent Technologies, Inc. | -3.67% | 68.99 | 1.6% | $216.32m | |
| EXAS | EXACT Sciences Corp. | -3.66% | 55.88 | 21.0% | $182.49m | |
| INCY | Incyte Corp. | 1.30% | 74.18 | 2.5% | $177.83m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.08% | 83.59 | 4.3% | $161.67m | |
| SGEN | Seattle Genetics, Inc. | -3.59% | 111.24 | 6.1% | $150.70m | |
| NVAX | Novavax, Inc. | 3.31% | 14.03 | 114.7% | $123.70m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -3.96% | 104.54 | 8.7% | $96.98m |
Company Profile
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include XERMELO, Zynquista, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.